Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Profiling in Insulin-Only Bionic Pancreas
NCT03262116Phase 3Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of BioChaperone Lispro in type 1 diabetes mellitus (T1D), sponsored by Massachusetts General Hospital. Started Mar 2019; status: terminated.
02
Drugs
BioChaperone Lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03262116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03262116.